Description:Upamostat, with the CAS number 590368-25-5, is a synthetic small molecule that functions primarily as a protease inhibitor. It has garnered attention in the field of medicinal chemistry due to its potential therapeutic applications, particularly in the treatment of various diseases, including certain types of cancer and viral infections. The compound exhibits a specific mechanism of action by inhibiting serine proteases, which are enzymes that play critical roles in numerous biological processes, including cell signaling and immune response. Upamostat is characterized by its ability to modulate proteolytic activity, thereby influencing tumor progression and viral replication. Its chemical structure includes functional groups that contribute to its binding affinity and specificity for target proteases. As research continues, Upamostat's pharmacokinetics, efficacy, and safety profile are being evaluated to better understand its potential as a therapeutic agent. Overall, Upamostat represents a promising candidate in the ongoing search for effective treatments in oncology and virology.
We use cookies to enhance your visit. We do not include advertising.
Please see our Cookies Policy for more details or adjust your preferences in "Settings".
This is the advanced settings system for our own and third-party cookies. Here you can modify parameters that will directly affect your browsing experience on this website. If you wish you may check the list of Cookie types.
Please note that disabling cookies can cause failures in the normal operation of the web.
